Estrogen Protects Bone by Inducing Fas Ligand in Osteoblasts to Regulate Osteoclast Survival

EMBO Journal - Germany
doi 10.1038/sj.emboj.7601984
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Interaction of Fas Ligand and Fas Expressed on Osteoclast Precursors Increases Osteoclastogenesis

Journal of Immunology
AllergyImmunology
2005English

Estrogen Inhibits Bone Resorption by Directly Inducing Apoptosis of the Bone-Resorbing Osteoclasts

Journal of Experimental Medicine
MedicineAllergyImmunology
1997English

Osteoclast Inducing Activity in Alveolar Bone Extract After Experimental Tooth Movement

The Journal of the Kyushu Dental Society
1996English

Osteoprotegerin Ligand Modulates Murine Osteoclast Survival in Vitro and in Vivo

American Journal of Pathology
Forensic MedicinePathology
2000English

Fas Receptor Is Required for Estrogen Deficiency-Induced Bone Loss in Mice

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2010English

Estrogen Action on Bone Marrow Osteoclast Lineage Cells of Postmenopausal Women in Vivo

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2008English

Nobiletin, a Polymethoxy Flavonoid, Suppresses Bone Resorption by Inhibiting NFκB-Dependent Prostaglandin E Synthesis in Osteoblasts and Prevents Bone Loss Due to Estrogen Deficiency

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2011English

Fas and Fas Ligand in Gut and Liver

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2000English

Estrogen Regulation of Apoptosis in Osteoblasts

Physiology and Behavior
PhilosophyBehavioral NeuroscienceExperimentalCognitive Psychology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy